NO20016089L - Nukleinsyrer og proteiner av det humane genet ABC1 - Google Patents

Nukleinsyrer og proteiner av det humane genet ABC1

Info

Publication number
NO20016089L
NO20016089L NO20016089A NO20016089A NO20016089L NO 20016089 L NO20016089 L NO 20016089L NO 20016089 A NO20016089 A NO 20016089A NO 20016089 A NO20016089 A NO 20016089A NO 20016089 L NO20016089 L NO 20016089L
Authority
NO
Norway
Prior art keywords
proteins
nucleic acids
human gene
abc1
gene abc1
Prior art date
Application number
NO20016089A
Other languages
English (en)
Other versions
NO20016089D0 (no
Inventor
Patrice Denefle
Marie-Francoise Rosier-Montus
Isabelle Arnould-Reguigne
Catherine Prades
Laurent Naudin
Cendrine Lemoine
Nicolas Duverger
Gerd Assmann
Stephan Rust
Harald Funke
H Bryan Brewer
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9907684A external-priority patent/FR2795091B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20016089D0 publication Critical patent/NO20016089D0/no
Publication of NO20016089L publication Critical patent/NO20016089L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
NO20016089A 1999-06-17 2001-12-13 Nukleinsyrer og proteiner av det humane genet ABC1 NO20016089L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9907684A FR2795091B1 (fr) 1999-06-17 1999-06-17 Acides nucleiques et proteines du gene abc1 humain et leur application en therapie et diagnostic
US14712899P 1999-08-04 1999-08-04
PCT/FR2000/001595 WO2000078970A1 (fr) 1999-06-17 2000-06-08 Acides nucleiques et proteines correspondant au gene abc1 humain

Publications (2)

Publication Number Publication Date
NO20016089D0 NO20016089D0 (no) 2001-12-13
NO20016089L true NO20016089L (no) 2002-02-15

Family

ID=26234994

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016089A NO20016089L (no) 1999-06-17 2001-12-13 Nukleinsyrer og proteiner av det humane genet ABC1

Country Status (11)

Country Link
EP (1) EP1190063A1 (no)
JP (1) JP2003503026A (no)
KR (1) KR20020012279A (no)
AU (1) AU5540800A (no)
BR (1) BR0011724A (no)
CA (1) CA2375771A1 (no)
HU (1) HUP0204524A2 (no)
IL (1) IL147071A0 (no)
MX (1) MXPA01013062A (no)
NO (1) NO20016089L (no)
WO (1) WO2000078970A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2367955C (en) 1999-03-15 2009-05-19 University Of British Columbia Abc1 polypeptide and methods and reagents for modulating cholesterol levels
CA2427436A1 (fr) * 2000-10-31 2002-05-10 Aventis Pharma S.A. Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection.
FR2815970A1 (fr) * 2000-10-31 2002-05-03 Aventis Pharma Sa Sequences polymorphes du gene humain abca1, leurs utilisations, les methodes et kits de detection
KR100801388B1 (ko) * 2002-01-02 2008-02-05 제넨테크, 인크. 종양의 진단 및 치료 방법 및 이를 위한 조성물
CN112442114A (zh) * 2019-08-29 2021-03-05 渥太华Hdl药物研发公司 一种多肽及其应用

Also Published As

Publication number Publication date
IL147071A0 (en) 2002-08-14
JP2003503026A (ja) 2003-01-28
WO2000078970A1 (fr) 2000-12-28
EP1190063A1 (fr) 2002-03-27
KR20020012279A (ko) 2002-02-15
HUP0204524A2 (hu) 2003-04-28
AU5540800A (en) 2001-01-09
NO20016089D0 (no) 2001-12-13
BR0011724A (pt) 2002-03-26
MXPA01013062A (es) 2002-06-04
CA2375771A1 (fr) 2000-12-28

Similar Documents

Publication Publication Date Title
EP1427746A4 (en) SYSTEMS FOR THE EXPRESSION OF PROTEINS AND NUCLEIC ACIDS
DK2325317T3 (da) Receptornukleinsyrer og polypeptidr
NO20013736D0 (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
AU1339701A (en) Anti-cancer nucleic acid and protein targets
NO20015828L (no) Fremgangsmåter for fremstilling av 5'-nukleinsyre- proteinkonjugater
DE69819124D1 (de) Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna
AU2003301883A8 (en) Modified luciferase nucleic acids and methods of use
NO991839D0 (no) FremgangsmÕter og preparater for utlevering og ekspresjon av interferon-<alfa>-nukleinsyrer
NO20016089L (no) Nukleinsyrer og proteiner av det humane genet ABC1
HUP0400492A3 (en) Nucleic acids of the human abc1 gene and applications thereof
DK1330525T3 (da) NOD2-nukleinsyrer og proteiner
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
EP1578913A4 (en) NUCLEIC ACIDS AND PROTEINS OF GENES OF THE OR83B SMOKE RECEPTOR FROM INSECTS AND USES THEREOF
GB2349150B (en) Expression of DNA or proteins in C. Elegans
EP1220896A4 (en) NEW HUMANE LIPASE PROTEINS, FOR CODING NUCLEIC ACIDS AND THEIR USE
DE69913654D1 (de) Nachweis von Nukleinsäuren im Zytoplasma
WO2000065063A3 (en) Nucleic acid vaccines against rickettsial diseases and methods of use
NO20021713D0 (no) Selv-kuttende RNA-sekvenser og deres anvendelse for kontroll av proteinsyntese
AU2002367841A8 (en) Bsnd nucleic acids and proteins
GB0021008D0 (en) Protein and nucleic acid sequence
NO20021967L (no) Nukleinsyrer til det humane ABC1-genet og deres terapeutiske og diagnostiske anvendelse
AU1517500A (en) Nucleic acids and proteins of the human span-x gene and uses thereof
DK1171454T3 (da) Kimære lyssavirusnukleinsyrer og polypeptider
IL144849A0 (en) Angiopoietin-related protein and nucleic acids
NO20021498L (no) Genet PRV-1 og anvendelsen av dette

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application